{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:34:15Z","timestamp":1793003655036,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05160-x","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:39:54Z","timestamp":1779683994000},"page":"4557-4567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the stone: nephrolithiasis as a metabolic sentinel in upper tract urothelial carcinoma and papillary renal cell carcinoma: toward a risk-stratified management framework"],"prefix":"10.1007","volume":"58","author":[{"given":"Sicheng","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"5160_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin I, Mamoulakis C, Miyazawa K et al (2017) Epidemiology of stone disease across the world. World J Urol 35:1301\u20131320. https:\/\/doi.org\/10.1007\/s00345-017-2008-6","journal-title":"World J Urol"},{"key":"5160_CR2","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41581-025-00990-x","volume":"21","author":"M Bargagli","year":"2025","unstructured":"Bargagli M, Scoglio M, Howles SA, Fuster DG (2025) Kidney stone disease:risk factors, pathophysiology and management. Nat Rev Nephrol 21:794\u2013808. https:\/\/doi.org\/10.1038\/s41581-025-00990-x","journal-title":"Nat Rev Nephrol"},{"key":"5160_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.eururo.2024.05.029","volume":"86","author":"A Skolarikos","year":"2024","unstructured":"Skolarikos A, Somani B, Neisius A et al (2024) Metabolic evaluation and recurrence prevention for urinary stone patients:an EAU guidelines update. Eur Urol 86:343\u2013363. https:\/\/doi.org\/10.1016\/j.eururo.2024.05.029","journal-title":"Eur Urol"},{"key":"5160_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41416-018-0356-7","volume":"120","author":"JAA van de Pol","year":"2019","unstructured":"van de Pol JAA, van den Brandt PA, Schouten LJ (2019) Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma:the Netherlands cohort study. Br J Cancer 120:368\u2013374. https:\/\/doi.org\/10.1038\/s41416-018-0356-7","journal-title":"Br J Cancer"},{"key":"5160_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00240-025-01758-5","volume":"53","author":"H Ziadeh","year":"2025","unstructured":"Ziadeh H, Calaway A, Gupta S et al (2025) Increased risk of upper tract urothelial carcinoma in patients with kidney stones:a large-scale analysis of the UK biobank. Urolithiasis 53:87. https:\/\/doi.org\/10.1007\/s00240-025-01758-5","journal-title":"Urolithiasis"},{"key":"5160_CR6","first-page":"277","volume":"10","author":"M Mihalopoulos","year":"2022","unstructured":"Mihalopoulos M, Yaghoubian A, Razdan S et al (2022) Understanding the link between kidney stones and cancers of the upper urinary tract and bladder. Am J Clin Exp Urol 10:277\u2013298","journal-title":"Am J Clin Exp Urol"},{"key":"5160_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1158\/1055-9965.EPI-24-0236","volume":"33","author":"M N\u00f8rgaard","year":"2024","unstructured":"N\u00f8rgaard M, K\u00f6rmendin\u00e9 Farkas D, Gotschalck MA, S\u00f8rensen HT (2024) Risk and prognosis of cancer in patients with obstructive uropathy compared with the general Danish population. Cancer Epidemiol Biomarkers Prev 33:1240\u20131247. https:\/\/doi.org\/10.1158\/1055-9965.EPI-24-0236","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5160_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrneph.2017.10","volume":"13","author":"SR Mulay","year":"2017","unstructured":"Mulay SR, Anders H-J (2017) Crystal nephropathies:mechanisms of crystal-induced kidney injury. Nat Rev Nephrol 13:226\u2013240. https:\/\/doi.org\/10.1038\/nrneph.2017.10","journal-title":"Nat Rev Nephrol"},{"key":"5160_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-025-01808-y","volume":"53","author":"SR Khan","year":"2025","unstructured":"Khan SR (2025) Oxidative stress, inflammation and kidney stones. Urolithiasis 53:137. https:\/\/doi.org\/10.1007\/s00240-025-01808-y","journal-title":"Urolithiasis"},{"key":"5160_CR10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/jnci\/89.19.1453","volume":"89","author":"WH Chow","year":"1997","unstructured":"Chow WH, Lindblad P, Gridley G et al (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89:1453\u20131457. https:\/\/doi.org\/10.1093\/jnci\/89.19.1453","journal-title":"J Natl Cancer Inst"},{"key":"5160_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000342","volume":"93","author":"C-J Shih","year":"2014","unstructured":"Shih C-J, Chen Y-T, Ou S-M et al (2014) Urinary calculi and risk of cancer:a nationwide population-based study. Medicine (Baltimore) 93:e342. https:\/\/doi.org\/10.1097\/MD.0000000000000342","journal-title":"Medicine (Baltimore)"},{"key":"5160_CR12","doi-asserted-by":"publisher","first-page":"E716","DOI":"10.5489\/cuaj.366","volume":"7","author":"S-D Chung","year":"2013","unstructured":"Chung S-D, Liu S-P, Lin H-C (2013) A population-based study on the association between urinary calculi and kidney cancer. Can Urol Assoc J 7:E716-721. https:\/\/doi.org\/10.5489\/cuaj.366","journal-title":"Can Urol Assoc J"},{"key":"5160_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/qjmed\/hcu195","volume":"108","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn W, Thongprayoon C, O\u2019Corragain OA et al (2015) The risk of kidney cancer in patients with kidney stones:a systematic review and meta-analysis. QJM 108:205\u2013212. https:\/\/doi.org\/10.1093\/qjmed\/hcu195","journal-title":"QJM"},{"key":"5160_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.23736\/S0393-2249.18.03113-2","volume":"70","author":"A Carbone","year":"2018","unstructured":"Carbone A, Al Salhi Y, Tasca A et al (2018) Obesity and kidney stone disease:a systematic review. Minerva Urol Nefrol 70:393\u2013400. https:\/\/doi.org\/10.23736\/S0393-2249.18.03113-2","journal-title":"Minerva Urol Nefrol"},{"key":"5160_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1097\/MOU.0000000000001041","volume":"32","author":"F Belladelli","year":"2022","unstructured":"Belladelli F, Montorsi F, Martini A (2022) Metabolic syndrome, obesity and cancer risk. Curr Opin Urol 32:594\u2013597. https:\/\/doi.org\/10.1097\/MOU.0000000000001041","journal-title":"Curr Opin Urol"},{"key":"5160_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2337\/cd21-0013","volume":"40","author":"A Bonilla-Sanchez","year":"2022","unstructured":"Bonilla-Sanchez A, Rojas-Munoz J, Garcia-Perdomo HA (2022) Association between diabetes and the risk of kidney cancer:systematic review and meta-analysis. Clin Diabetes 40:270\u2013282. https:\/\/doi.org\/10.2337\/cd21-0013","journal-title":"Clin Diabetes"},{"key":"5160_CR17","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/HJH.0000000000001286","volume":"35","author":"K Hidayat","year":"2017","unstructured":"Hidayat K, Du X, Zou S-Y, Shi B-M (2017) Blood pressure and kidney cancer risk:meta-analysis of prospective studies. J Hypertens 35:1333\u20131344. https:\/\/doi.org\/10.1097\/HJH.0000000000001286","journal-title":"J Hypertens"},{"key":"5160_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.816756","volume":"10","author":"L Yue","year":"2022","unstructured":"Yue L, Pai Q, Wu X, Zhang J (2022) Smoking and risk of urolithiasis:meta-analysis of observational studies. Front Public Health 10:816756. https:\/\/doi.org\/10.3389\/fpubh.2022.816756","journal-title":"Front Public Health"},{"key":"5160_CR19","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti T-D (2021) NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 22:550\u2013559. https:\/\/doi.org\/10.1038\/s41590-021-00886-5","journal-title":"Nat Immunol"},{"key":"5160_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga TT, Forni MF, Correa-Costa M et al (2017) Soluble uric acid activates the NLRP3 inflammasome. Sci Rep 7:39884. https:\/\/doi.org\/10.1038\/srep39884","journal-title":"Sci Rep"},{"key":"5160_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108545","volume":"251","author":"IW Tengesdal","year":"2023","unstructured":"Tengesdal IW, Dinarello CA, Marchetti C (2023) NLRP3 and cancer:pathogenesis and therapeutic opportunities. Pharmacol Ther 251:108545. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108545","journal-title":"Pharmacol Ther"},{"key":"5160_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1109938","author":"X Zhan","year":"2023","unstructured":"Zhan X, Li Q, Xu G et al (2023) The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1109938","journal-title":"Front Immunol"},{"key":"5160_CR23","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1096\/fj.201903266RR","volume":"34","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wang J, Zhou K et al (2020) Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC. FASEB J 34:7927\u20137940. https:\/\/doi.org\/10.1096\/fj.201903266RR","journal-title":"FASEB J"},{"key":"5160_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/path.4940","volume":"243","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zhang Z, Wei H et al (2017) Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42-PAK1 axis. J Pathol 243:208\u2013219. https:\/\/doi.org\/10.1002\/path.4940","journal-title":"J Pathol"},{"key":"5160_CR25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41586-024-07754-w","volume":"632","author":"B Roje","year":"2024","unstructured":"Roje B, Zhang B, Mastrorilli E et al (2024) Gut microbiota carcinogen metabolism causes distal tissue tumours. Nature 632:1137\u20131144. https:\/\/doi.org\/10.1038\/s41586-024-07754-w","journal-title":"Nature"},{"key":"5160_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s12276-022-00777-1","volume":"54","author":"X Li","year":"2022","unstructured":"Li X, Hu J, Zhao X et al (2022) Piezo channels in the urinary system. Exp Mol Med 54:697\u2013710. https:\/\/doi.org\/10.1038\/s12276-022-00777-1","journal-title":"Exp Mol Med"},{"key":"5160_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06185-1","volume":"14","author":"W Hao","year":"2023","unstructured":"Hao W, Zhang H, Hong P et al (2023) Critical role of VHL\/BICD2\/STAT1 axis in crystal-associated kidney disease. Cell Death Dis 14:680. https:\/\/doi.org\/10.1038\/s41419-023-06185-1","journal-title":"Cell Death Dis"},{"key":"5160_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1192495","volume":"14","author":"W Zhu","year":"2023","unstructured":"Zhu W, Zhao R, Guan X, Wang X (2023) The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression. Front Pharmacol 14:1192495. https:\/\/doi.org\/10.3389\/fphar.2023.1192495","journal-title":"Front Pharmacol"},{"key":"5160_CR29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.eururo.2015.07.040","volume":"69","author":"C T\u00fcrk","year":"2016","unstructured":"T\u00fcrk C, Pet\u0159\u00edk A, Sarica K et al (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69:468\u2013474. https:\/\/doi.org\/10.1016\/j.eururo.2015.07.040","journal-title":"Eur Urol"},{"key":"5160_CR30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.advnut.2023.03.002","volume":"14","author":"P Peerapen","year":"2023","unstructured":"Peerapen P, Thongboonkerd V (2023) Kidney stone prevention. Adv Nutr 14:555\u2013569. https:\/\/doi.org\/10.1016\/j.advnut.2023.03.002","journal-title":"Adv Nutr"},{"key":"5160_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.55730\/1300-0144.5779","volume":"54","author":"TE \u015eener","year":"2024","unstructured":"\u015eener TE, Tailly T, Tanidir Y et al (2024) Urologists\u2019 opinion on treating asymptomatic stones: would we treat ourselves as we treat our patients? Survey from European Association of Urology, Young Academic Urologists, Endourology and Urolithiasis working party. Turk J Med Sci 54:185\u2013193. https:\/\/doi.org\/10.55730\/1300-0144.5779","journal-title":"Turk J Med Sci"},{"key":"5160_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/iju.70004","volume":"32","author":"K Miyazawa","year":"2025","unstructured":"Miyazawa K, Yamaguchi S, Iguchi T et al (2025) Summary of the clinical practice guideline for the management of urinary stones, third edition. Int J Urol 32:462\u2013474. https:\/\/doi.org\/10.1111\/iju.70004","journal-title":"Int J Urol"},{"key":"5160_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152467","volume":"17","author":"D Escobar","year":"2025","unstructured":"Escobar D, Wang C, Suboc N et al (2025) Diagnosis and management of upper tract urothelial carcinoma: a review. Cancers (Basel) 17:2467. https:\/\/doi.org\/10.3390\/cancers17152467","journal-title":"Cancers (Basel)"},{"key":"5160_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16061115","volume":"16","author":"SD Pandolfo","year":"2024","unstructured":"Pandolfo SD, Cilio S, Aveta A et al (2024) Upper tract urothelial cancer: guideline of guidelines. Cancers (Basel) 16:1115. https:\/\/doi.org\/10.3390\/cancers16061115","journal-title":"Cancers (Basel)"},{"key":"5160_CR35","doi-asserted-by":"publisher","first-page":"246.e1","DOI":"10.1016\/j.urolonc.2024.03.008","volume":"42","author":"A Hannemann","year":"2024","unstructured":"Hannemann A, Pessoa RR, Flaig T et al (2024) Cost of upper tract imaging obtained during hematuria evaluation: analysis of a national claims database. Urol Oncol 42:246.e1-246.e5. https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.008","journal-title":"Urol Oncol"},{"key":"5160_CR36","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1001\/jamapediatrics.2021.2966","volume":"175","author":"GE Tasian","year":"2021","unstructured":"Tasian GE, Denburg MR, Ellison JS (2021) Early-onset kidney stone disease-consequences and opportunities. JAMA Pediatr 175:1203\u20131204. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.2966","journal-title":"JAMA Pediatr"},{"key":"5160_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/MOU.0000000000001328","volume":"36","author":"MY Man","year":"2026","unstructured":"Man MY, Somani B, Pietropaolo A (2026) Does surgical removal of kidney stones help prevent the recurrence of urinary tract infections? A systematic review. Curr Opin Urol 36:103\u2013111. https:\/\/doi.org\/10.1097\/MOU.0000000000001328","journal-title":"Curr Opin Urol"},{"key":"5160_CR38","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.21037\/tau-24-326","volume":"13","author":"Z Shan","year":"2024","unstructured":"Shan Z, Deng X, Yang L, Zhang G (2024) Diagnostic status and new explorations in upper urinary tract urothelial carcinoma:a literature review. Transl Androl Urol 13:2570\u20132586. https:\/\/doi.org\/10.21037\/tau-24-326","journal-title":"Transl Androl Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05160-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05160-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05160-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:02:41Z","timestamp":1793001761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05160-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["5160"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05160-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}